Background {#Sec1}
==========

The South Korean Schedule for the Enforcement Decree of the Industrial Accident Compensation Act was amended in July 2013 to provide specific criteria for the recognition of occupational diseases, including occupational cancer. This amendment increased the official recognition from 9 cancers and 9 carcinogens to 21 cancers and 23 carcinogens. For example, the amendment formally recognized "leukemia and nasopharyngeal cancer \[NPC\] caused by formaldehyde \[formaldehyde\] exposure" \[[@CR1], [@CR2]\]. However, there are few detailed scientific reviews that have considered the relationship between formaldehyde exposure and leukemia in Korea.

The International Agency for Research on Cancer (IARC) officially classified formaldehyde as a "definite human carcinogen" for NPC in 2004 and for leukemia in 2012 \[[@CR3], [@CR4]\]. Other authorities have also acknowledged the possibly carcinogenic role of formaldehyde, including the American Environmental Protection Agency (EPA), the European Union Occupational Disease Classification, Labelling and Packaging of Substances and Mixtures (EU CLP) guidelines, and the American Conference of Governmental Industrial Hygienists (ACGIH) \[[@CR5]--[@CR7]\]. However, the 2010 amendment of the International Labor Organization (ILO) guidelines did not reach a consensus regarding whether occupational formaldehyde exposure was directly linked to NPC or leukemia \[[@CR8]\]. Nevertheless, formaldehyde-related cancers are included in the lists of recognized occupational diseases in France, Denmark, Taiwan, and Malaysia \[[@CR9]--[@CR11]\].

Given the international trend towards recognizing formaldehyde-related occupational disease, and the absence of Korean reviews, we reviewed epidemiological studies and other evidence from Korea. We also present points for consideration during the process of determining whether formaldehyde-related NPC and leukemia should be considered work-related.

Methods {#Sec2}
=======

We initially reviewed various scientific papers, including many epidemiological studies, regarding the causal relationship between formaldehyde exposure and cancer. Second, we reviewed various scientific papers, industrial reports, occupational exposure level reports, population data, and task force reports regarding exposure in Korean. Third, we reviewed various reports and epidemiological studies (including cohort studies, case-control studies, meta-analyses, reviews, and experimental studies) regarding the carcinogenicity of formaldehyde. Fourth, we investigate the national regulations regarding officially recognized occupational diseases and the international classifications for carcinogenicity. Finally, we considered the issues that could influence or determine the causal relationship between occupational exposure and cancer.

Results {#Sec3}
=======

Use and exposure in South Korea {#Sec4}
-------------------------------

Formaldehyde is mainly used in the production of various resins, although it is also used extensively as an intermediate during the manufacture of various industrial chemicals and directly as an aqueous disinfectant \[[@CR3], [@CR4]\]. The highest average exposures (2--5 ppm; 2.5--6.1 mg/m^3^) were measured during furniture and floor varnishing, textile finishing, fur treatment, in the garment industry, and in certain jobs at manufactured board mills and foundries. Short-term exposures to high levels (≥3 ppm; ≥3.7 mg/m^3^) have been reported for embalmers and pathologists \[[@CR3]\].

In South Korea, employees who are exposed to formaldehyde have regular mandatory health examinations, which are mandatory for workers who are exposed to workplace hazards. Approximately 18,000 employees had formaldehyde-related health examinations during 2008, which accounted for 2.07% of all specific health examinations. Almost all specific health examinations were performed for people who worked in the manufacturing industry or in health and social work activities (Table [1](#Tab1){ref-type="table"}).Table 1Number of workers examined special health check for formaldehyde by types of industries and years in Korea, 2001--2010Industry200120022003200420052006200720082009D. Manufacturing335943524912525755277220537190508305P. Human health and social work activities10810721366191523242845220446434473N. Public administration and defense; compulsory social security1319710361323113531281018R. Membership organizations, repair and other personal services326912517625522294461131M. Business facilities management and business support services331510714784191172302510F. Construction1425161237916586Others122411111312691698396Total3545553666597821947511,971906117,72514,539Industries are classified by the 8th Korean standard industrial classificationSource: Kim EA et al. \[[@CR12]\]

Table [2](#Tab2){ref-type="table"} shows the formaldehyde exposure levels using a threshold limit value-time weighted average (TLV-TWA), based on national data regarding working environment measurements from 2002 to 2010. The highest number of samples was observed in industries that manufactured chemicals and chemical products, which was followed by the manufacture of motor vehicles, trailers and semitrailers, and non-furniture wood and cork products \[[@CR12]\].Table 2Top 15 number of samples of measurement of concentration of work-environmental formaldehyde by sub-categories of industries in Korea, 2002--2010IndustryNo. of samples (A)No. of detected samples (B)Detection rate (B/A)Geometric mean, ppm (range)24. Manufacture of chemicals and chemical products537047270.8800.022 (0--25.598)34. Manufacture of motor vehicles, trailers and semitrailers339629290.8620.011 (0--41.543)20. Manufacture of wood products of wood and cork;except furniture307529290.9530.053 (0--62.479)32. Manufacture of electrical components, audio, visual and communication equipment293226080.8890.020 (0--1.443)27. Manufacture of basic metal products274924140.8780.015 (0--45.706)17. Manufacture of textiles, except apparel240921350.8860.016 (0--16.800)36. Manufacture of furniture and others222720770.9330.024 (0--4.152)29. Manufacture of other machinery and equipment172212860.7470.014 (0--7.711)85. Human health service163013190.8090.023 (0--25.300)26. Manufacture of other non-metallic mineral products120710750.8910.034 (0--26.800)28. Manufacture of fabricated metal products, except machinery and furniture10209220.9040.023 (0--2.010)25. Manufacture of rubber and plastic products8917450.8360.020 (0--0.990)21. Manufacture of pulp, paper and paper products7396320.8550.013 (0--2.384)31. Manufacture of electrical equipment5584460.8620.006 (0--32.900)73. Scientific research and development5011070.9530.016 (0--1.500)Industries are classified by the 8th Korean standard industrial classificationSource: Kim EA et al. \[[@CR12]\]

Table [3](#Tab3){ref-type="table"} shows the results of the formaldehyde exposure levels based on results from academic reports in Korea. The maximum exposure level was 5.01 ppm in histological laboratories from nine general hospitals \[[@CR13]\]. The maximum formaldehyde exposure level was 3.91 ppm among 80 students in a gross anatomy laboratory, which was sampled five times in four areas \[[@CR14]\]. The maximum formaldehyde exposure level was 14.77 ppm among 48 workers in the endoscopy units of four general hospitals \[[@CR15]\].Table 3Cross-sectional studies about workplace measurements of formaldehyde in KoreaAuthors (Years)Subjects and measurementsFormaldehyde concentration, ppm\
Geometric mean (range)Park et al., (1998) \[[@CR13]\]19 workers in 9 histological laboratories in each hospitals. Personal and area sampling to assess TWA and STELTWA (8 h)\
Personal 0.31 (0.02--3.86)\
Area 0.61 (0.08--1.49).\
STEL (15 min)\
Personal 1.88 (0.59--5.01)\
Area 1.42 (0.31--4.24)Park et al.,(2006) \[[@CR14]\]80 students in a gross anatomy laboratory in a college of medicine. Area sampling at 4 spots 5 times eachTWA (8 h)\
Area 1.51 (0.26--3.91)Kim et al. (2009) \[[@CR15]\]48 workers in endoscopy units in 4 hospitals. Personal samplings to assess TWA and STEL.TWA (8 h)\
Personal 0.056 (0.003--0.923)\
STEL (15 min)\
Personal 1.428 (0.103--14.773)Lee et al., (2012) \[[@CR16]\]In curling and compounding process of two tire plants, 12 personal sampling to assess TWA.TWA (8 h)\
Personal 0.029 (0.027--0.029) (highest within 4 spots)Yoo et al.,(2014) \[[@CR17]\]Workers handle medium density fiberboard and veneer in a furniture manufacturing factory. Air concentration of formaldehyde handling wood glue and wet veneer at room temperature, 100 °C and 150 °C(Handling wet veneer at 150 °C, 2.70 ppm)Gu et al., (2014) \[[@CR18]\]62 nurses in 8 ambulatory care units in 2 hospitals. Personal samplings to assess TWA.TWA (8 h)\
Personal 0.023 (0.001--0.258)TWA, Time weighted average; STEL, Short-term exposure limit

The highest concentration of formaldehyde was 0.029 ppm in the compounding process of two tire manufacturing plants \[[@CR16]\]. A furniture manufacturing factory had a formaldehyde concentration of 2.7 ppm when handling wet veneer at 150 °C \[[@CR17]\]. The maximum formaldehyde exposure level was 0.258 ppm among 62 nurses in two university hospitals \[[@CR18]\].

Epidemiological studies {#Sec5}
-----------------------

### NPC {#Sec6}

The main epidemiological results for NPC have been obtained from a National Cancer Institute (NCI) cohort that included 10 plants that produced or used formaldehyde. The results revealed a significantly increase risk of death because of NPC and dose-response relationships with both peak and cumulative formaldehyde exposures \[[@CR19]\]. The strength of the associations weakened and the dose-response relationships for cumulative exposure levels disappeared after 10 years of follow-up \[[@CR20]\]. Marsh et al. reported that this result was related to the effect of the first factory, and they reported that the excess death because of NPC was the result of a work history involving silversmithing or other metal processing \[[@CR21], [@CR22]\]. However, the IARC committee concluded that the effect modification based on silversmithing or other confounding could not explain the excess death because of NPC \[[@CR4]\]. Another cohort study of a British chemical plant, an American clothing manufacturer, a Finish cancer registry, and an Italian plastic factory did not detect a significant risk of formaldehyde-related NPC, with the exception of an unexplained cluster of deaths because of NPC at plant 1 in the NCI cohort \[[@CR23]--[@CR28]\] (Table [4](#Tab4){ref-type="table"}). Several case-control studies have also reported a significant relationship or dose-response relationship between the highest formaldehyde exposure and NPC \[[@CR29]--[@CR31]\]. However, we did not detect significant relationships in other studies \[[@CR32]--[@CR35]\] (Table [5](#Tab5){ref-type="table"}). The results from a meta-analysis (excluding plant 1 of the NCI cohort) are shown in Table [6](#Tab6){ref-type="table"}, and the meta-risk was 0.72 (95% confidence interval \[CI\]: 0.40--1.29) \[[@CR36]--[@CR38]\].Table 4Cohort studies of formaldehyde exposures and nasopharyngeal cancerAuthors (Years), CountryCohort description\
Type of analysis (cohort size)Exposure assessmentResults\
SMR or RR (95% CI)Hauptmann et al.(2004), USA \[[@CR19]\]The cohort with 10 plants of manufacture of or using formaldehyde by the National Cancer Institute from 1966 to 1994; Standardized mortality (25,619 workers; 22,493 men, 3126 women) and Relative risksDuration; quantitative estimates of cumulative, average and highest peak exposure8 death, SMR 2.10 (1.05--4.21)\
Peak exposure (ppm)\
≥4.0 RR 1.83 (*p*-trend \< 0.001)\
Cumulative exposure (ppm-year)\
1.5--\< 5.5 RR 1.19,\
≥5.5 RR 4.14 (*p*-trend = 0.025)Freeman et al. (2013), USA \[[@CR20]\]Update of Hauptmann et al.(2004), 1966--2004Duration; quantitative estimates of cumulative, average and highest peak exposure9 death, SMR 1.84 (0.84--3.49);\
Peak Exposure (ppm)\
≥4.0 RR 7.66 (0.94--62.34) (*p*-trend = 0.005)Marsh et al. (2005), USA \[[@CR21]\]Computed SMRs and RRs for each of 10 study plants and by plant group (Plant 1 (*n* = 4261) vs. Plants 2--10 (*n* = 21,358)).\
1966--1994Duration; quantitative estimates of cumulative, average and highest peak exposurePlant 1\
6 deaths, SMR 10.32 (3.79--22.47)\
plant 2--10\
2 deaths, SMR 0.65 (0.08--2.33)Coggon et al. (2003), UK \[[@CR23]\]Chemical factories that used or produced Formaldehyde; Standardized mortality (14,014 men); 1941--2000Level of exposure (background, low, moderate, high); among highly exposed, time period and duration of exposureOne death from nasopharyngeal cancer (2.0 expected)Coggon et al. (2014), UK \[[@CR24]\]Update of Coggon et al., (2003). (14,008 men); 1941--2012Level of exposure (background, low, moderate, high); among highly exposed, time period and duration of exposureOne death from nasopharyngeal cancer (1.7 expected)Pinkerton et al. (2004), USA \[[@CR25]\]Garment industry; Standardized mortality (11,039 workers; 2015 men, 9024 women)Duration, time since first exposure, year of first exposureNo death from nasopharyngeal cancer (0.96 expected)Meyers et al. (2013), USA \[[@CR26]\]Garment industry; Standardized mortality (11,039 workers; 2015 men, 9024 women)Duration, time since first exposure, year of first exposureNo death from nasopharyngeal cancer (0.96 expected)Siew et al. (2012), Finland \[[@CR27]\]All Finnish men born between 1906 and 1945 and employed during 1970, Finnish Cancer Registry for cases of cancers of nasopharynx (*n* = 149) (*n* = 30,317). 1971--1995.Estimation of exposure by Finnish Job Exposure MatrixAny exposure to formaldehyde\
RR 0.87 (0.34--2.20)\
Any exposure to wood dust\
RR 0.66 (0.30--1.45)Pira et al. (2012), Italia \[[@CR28]\]Workers of a laminated plastic factory in Piedmont, northern Italy. 2750 subjects (2227 men and 523 women) between 1947 and 2011, for at least 180 days. SMRsNoneNo nasopharyngeal cancer was confirmed.SMR, Standardized mortality ratio; RR, Relative riskTable 5Case-control studies of formaldehyde exposure and nasopharyngeal cancerAuthors (Years), CountryCharacteristics of cases and controlsExposure assessmentExposure categoriesOR (95% CI)Marsh et al. (2007), USA \[[@CR22]\]7 incidental cases who died from nasopharyngeal cancer during 1945--2003; case was matched on exact age race, sex, and year of birth (±2 years) to four controls from the members of the cohort.Evaluation of formaldehyde exposure while accounting for potential confounding or effect modification by smoking or external (non-Wallingford) employment.Silver smithingNever1.0 (Ref)Ever14.41 (1.30--757.8)*p*-trend0.024Silver smithing or other metal workNever1.0 (Ref)Ever7.31 (1.08--82.1)*p*-trend0.047Olsen et al. (1984), Denmark \[[@CR32]\]754 cases from the Danish Cancer Registry including 266 nasopharyngeal cancers; controls were 2465 patients with cancers of the colon, rectum, prostate and breast; frequency matched by sex, age (± 5 years) and year of diagnosis (± 5 years)Record linkage with pension fund with compulsory membership; job title from Central Pension Registry; exposure assessed blindly as certain, probable, unlikely, unknownMen0.7(0.3--1.7)Women2.6(0.3--21.9)Vaughan et al. (1986), USA \[[@CR33]\]285 incidental cases identified by the local Cancer Surveillance System, aged 20--74 years, including 27 cases of cancer of nasopharynx; controls were 552 identified by random-digit dialingJob--exposure linkage system based on industry and occupation, resulting in four categories: high, medium, low and backgroundLow exposure1.2 (0.5--3.3)Medium or High1.4 (0.4--4.7)Exposure years1--91.2 (0.5--3.1)10+1.6 (0.4--5.8)Exposure scores5\~ 190.9 (0.5--5.7)20+2.1 (0.6--7.8)Roush et al. (1987), USA \[[@CR29]\]173 nasopharyngeal cancers registered at the Connecticut Tumor Registry; Controls were 605 men who died during the same period, selected by random sampling without matching or stratificationJob title, industry, specific employment, year of employment, obtained from death certificates and city directories to determine occupation at 1, 10, 20, 25, 30, 40 and 50 years prior to deathProbably exposed for most of working2.7 (1.1--6.6)life1.2 (0.5--3.2)+ exposure \> 20 years before death2.9 (1.1--7.6)+ exposure to high level for some years4.0 (1.3--12.3)+ exposure to high level \> 20 years before deathWest et al. (1993), Philippines \[[@CR30]\]104 incidental cases (76 men, 28 women) histologically confirmed; 104 hospital controls matched for sex, age and hospital ward type and 101 community controls matched for sex, age and neighborhoodOccupational history; occupation classified as likely or unlikely to involve exposure to formaldehyde; duration of exposure; 10-year lag period; years since first exposure; age at start of exposureExposure year\<  15 years2.7 (1.1--6.6)\>  15 years1.2 (0.5--3.2)\<  15 years (10-year lag)2.9 (1.1--7.6)\>  15 years (10-year lag)4.0 (1.3--12.3)Vaughan et al. (2000), USA \[[@CR31]\]196 men and women from five cancer registries, aged 18--74 years controls were 244 population based selected by random digit dialing, and frequency matched by sex, cancer registry and age (5-year groups)Structured telephone interviews; occupational exposures assessed by a job--exposure matrixDuration (years)1--50.9 (0.4--2.1)6--171.9 (0.9--4.4)\> 182.7 (1.2--6.0)*p*-trend0.014Cumulative exposure (ppm-years)0.05--0.40.9 (0.4--2.0)0.4--1.101.8 (0.8--4.1)\>  1.103.0 (1.3--6.6)*p*-trend0.03Armstrong et al. (2000), Malaysia \[[@CR34]\]282 histologically confirmed cases of nasopharyngeal carcinoma in Chinese men and women from four centers who had lived in the area for \> 5 years;One Chinese control selected by multistage area sampling per case, matched by age and sexStructured in-home interviews;\
Occupational exposures assessed by a job--exposure matrixAny (unadjusted)1.24 (0.67--2.32)Any (adjusted)0.71 (0.34--1.41)Hildesheim et al. (2001), Taipei \[[@CR35]\]375 histologically confirmed hospital cases (31% women), aged \< 75 years; 325 community controls, individually matched on sex, age (5 years) and district of residenceStructured in person interviews; occupational exposures assessed by an industrial hygienistEver exposed1.4 (0.93--2.2)Duration1--10 years1.3 (0.69--2.3)\> 10 years1.6 (0.91--2.9)*p*-trend0.08OR, Odds ratioTable 6Meta-analysis of formaldehyde exposure and nasopharyngeal cancerAuthors, (Years)StudiesOverall OR or RR (95% CI)Collins et al.,(1997) \[[@CR36]\]Cohort studies with reported expected deaths\
Industrial cohort studies\
Case-control studies\
All Studies1.6 (0.8--3.0)\
1.2 (0.4--2.5)\
1.3 (0.9--2.1)\
1.3 (1.2--1.5)Bosetti et al. (2008) \[[@CR37]\]Hauptmann et al. 2004-plant 1\
Hauptmann et al. 2004-plants 2--10\
Industrial cohort studies9.10 (4.09--20.26)\
0.64 (0.16--2.56)\
1.33 (0.69--2.56)Bachand et al. (2010) \[[@CR38]\]Cohort studies (excluding single plant)\
Case control studies0.72 (0.40--1.29)\
1.22 (1.00--1.50)

Lymphohematopoietic malignancies {#Sec7}
--------------------------------

Six of the seven mortality studies involving professional workers (e.g., embalmers, funeral directors, pathologists, and anatomists) revealed positive associations between formaldehyde exposure and lymphohematopoietic malignancies (LHM) \[[@CR39]--[@CR45]\] (Table [7](#Tab7){ref-type="table"}). The NCI cohort compared deaths from 2004 and 1994, and found that the strength of association between formaldehyde exposure and death because of leukemia and myeloid leukemia was weakened. Furthermore, the peak-exposure category (≥4.0 ppm) exhibited dose-response relationships with LHM, myeloid leukemia, and Hodgkin lymphoma \[[@CR46]--[@CR48]\]. Three cohort studies failed to detect a significantly increased risk of death \[[@CR23]--[@CR26]\]. Three case-control studies of formaldehyde exposure and leukemia also failed to detect a significantly increased risk \[[@CR49]--[@CR51]\]. A nested case-control study of funeral professionals revealed that the risks of non-lymphoid LHM or myeloid leukemia increased with working experience \[[@CR52]\] (Table [8](#Tab8){ref-type="table"}). Table [9](#Tab9){ref-type="table"} shows results from a meta-analysis of the relationship between formaldehyde exposure and leukemia \[[@CR37], [@CR38], [@CR53]--[@CR55]\]. The risk estimate for all leukemia was 1.05 (95% CI: 0.93--1.20) when researchers included the recent NCI cohort and excluded proportionate mortality studies \[[@CR38]\]. The meta-risks including the NCI cohort and American funeral industries were 1.53 (95% CI: 1.11--2.21) for all leukemia and 2.47 (95% CI:1.42--4.27) for myeloid leukemia \[[@CR55]\]. Nevertheless, researchers have not reached a consensus regarding any causal association or dose-response relationship between formaldehyde exposure and LHM, including myeloid leukemia \[[@CR56], [@CR57]\]. However, there appears to be a causal association between formaldehyde exposure, and especially peak exposures of ≥4 ppm, and all LHM (including Hodgkin lymphoma but not leukemia).Table 7Cohort studies of formaldehyde exposures and exposures and lymphohematopoietic malignanciesAuthors (Years), CountryCohort description\
Type of analysis (cohort size)Exposure assessmentResults\
SMR or PMR (95% CI)Walrath et al. (1983), USA \[[@CR39]\]Embalmers and funeral directors,\
PMR/PCMR (1132 white men); 1925--80Time since first license, age at first licenseLHM 25 deaths PMR 1.21\
Leukemia 12 deaths PCMR 1.19\
Myeloid leukemia 6 deaths PCMR 1.5Walrath et al. (1984), USA \[[@CR40]\]Embalmers, PMR/PCMR(1007 white men)DurationLHM 19 deaths PCMR 1.22\
Leukemia 12 deaths PCMR 1.40\
Myeloid leukemia 6 deaths PCMR 1.50Levine et al. (1984), Canada \[[@CR41]\]Embalmers, SMR(1413 men); 1950--77NoneLHM 8 deaths SMR 1.23 (0.53--2.43)\
Leukemia 4 deaths SMR 1.60 (0.44--4.10)Stroup et al. (1986), USA \[[@CR42]\]Anatomists, SMR (2239 men); 1925--79DurationLHM 18 deaths SMR 1.2 (0.7--2.0)\
Lymphoma 2 deaths SMR 0.7 (0.1--2.5)\
Leukemia 10 deaths SMR 1.5 (0.7--2.7)\
CML 3 deaths SMR 8.8 (1.8--25.5)\
Other lymphoma 6 deaths SMR 2.0 (0.7--4.4)Logue et al. (1986), USA \[[@CR43]\]Pathologists, SMR (5585 men); 1962--77NoneLHM SMR 0.48\
Leukemia SMR 1.06Hayes et al. (1990), USA \[[@CR44]\]Embalmers/funeral directors, PMR(3649 white men, 397 non-white men); 1975--85NoneLHM\
100 deaths PMR 1.31 (1.06--1.59) (White)\
15 deaths PMR 2.41 (1.35--3.97) (Non-white)\
Myeloid leukemia\
23 deaths PMR 1.61 (1.02--2.41) (White)\
1 death PMR 1.06 (0.02--5.93) (Non-white)\
Other unspecified leukemia\
17 deaths PMR 2.08 (1.21--3.34) (White)\
3 deaths PMR 4.92 (1.01--14.36) (Non-white)Hall et al. (1991), UK \[[@CR45]\]Pathologists; SMR; 4512 (data presented for 3872, 802 women, 3069 men); 1974--87NoneLHM 10 deaths SMR 1.44 (0.69--2.65)\
Hodgkin lymphoma 1 death SMR 1.21 (0.03--6.71)\
Leukemia 10 deaths SMR 1.5 (0.7--2)Hauptmann et al. (2003), USA \[[@CR46]\]The cohort composed of 10 plants of manufacture of or using by the National Cancer Institute during 1966--1994; Standardized mortality (25,619 workers; 22,493 men, 3126 women) and Relative risksDuration; quantitative estimates of cumulative, average and highest peak exposurePeak exposure (ppm)\
LHM\
2.0--3.9 RR 1.71 (1.14--2.58)\
≥4 RR 1.87 (1.27--2.75) (*p*-trend, 0.002)\
Leukemia\
2.0--3.9 RR 2.04 (1.04--4.01)\
≥4 RR 2.46 (1.31--4.62) (*p*-trend, 0.004)\
Myeloid leukemia\
≥4 RR 3.46 (1.27--9.43) (*p*-trend, 0.009)Freeman et al. (2009), USA \[[@CR47]\]Update of Hauptmann et al.(2003); 1966--2004Duration; quantitative estimates of cumulative, average and highest peak exposurePeak exposure (ppm)\
LHM\
≥4 RR 1.37 (1.03--1.81) (*p*-trend, 0.02)\
Hodgkin lymphoma\
2.0--3.9 RR 3.30 (1.04--10.50)\
≥4 RR 3.96 (1.31--12.02) (*p*-trend, 0.01)Checkoway et al. (2015), USA \[[@CR48]\]Re-analyses of Freeman et al. (2009), Analysis of full cohort (*n* = 25,619) and workers employed 1 year or longer (*n* = 16,306); Cox proportional hazards analyses; 1966--2004Duration; quantitative estimates of cumulative, average and highest peak exposureWorked ≥1 year, Peak Exposure (ppm)\
Hodgkin lymphoma\
≥2.0--*\<* 4 HR 3.50 (1.06--11.56)\
≥4 HR 5.13 (1.67--15.77) (*p*-trend, 0.003)\
All leukemia\
≥2.0--*\<* 4 HR 2.46 (1.29--4.67)\
≥ HR 2.45 (1.32--4.52) (*p*-trend, 0.002)Coggon et al. (2003), UK \[[@CR23]\]Garment industry; Standardized\
Mortality (11,039 workers), 1955--1998Duration, time since first exposure, year of first exposureLHM 59 deaths SMR 0.97 (0.74--1.26)\
Leukemia 24 deaths SMR 1.09 (0.70--1.62)\
Myeloid leukemia 15 death SMR 1.44 (0.80--2.37)Coggon et al. (2014), UK \[[@CR24]\]Update of Pinkerton et al., (2004). (11,043 workers), 1955--2008LHM 107 deaths SMR 1.11 (0.91--1.34)\
Leukemia 36 deaths SMR 1.04 (0.73--1.44)\
Myeloid leukemia 21 death SMR 1.28 (0.79--1.96)Pinkerton et al. (2004), USA \[[@CR25]\]Chemical ctories that used or produced Formaldehyde; Standardized mortality (14,014 men); 1941--2000Level of exposure (background, low, moderate, high); among highly exposed, time period and duration of exposureLeukemia\
All subjects 31 deaths SMR 0.91 (0.62--1.29)\
High exposure 9 deaths SMR 0.71 (0.31--1.39)Meyers et al. (2013), USA \[[@CR26]\]Update of Coggon et al., (2003). (14,008 men); 1941--2012Level of exposure (background, low, moderate, high); among highly exposed, time period and duration of exposureLeukemia\
All subjects 36 deaths SMR 1.02 (0.77--1.33)\
High exposure 13 deaths SMR 0.82 (0.44--1.41)SMR, Standardized mortality ratio; LHM, Lymphohematopoietic malignanciesSMR, Standardized mortality ratio; PMR, Proportionate mortality ratio; PCMR, Proportionate cancer mortality ratio; LHM, Lymphohematopoietic malignancies; CML, Chronic myeloid leukemiaRR, Relative risk; LHM, Lymphohematopoietic malignancies; HR, Hazard ratioTable 8Case-control studies of formaldehyde exposure and lymphohemtopoietic malignanciesAuthors (Years), CountryCharacteristics of cases and controlsExposure assessmentExposure categoriesOR (95% CI)Lions et al. (1990), USA \[[@CR49]\]578 male cases of leukemia and 722 non-Hodgkin lymphoma; 1245 population-based controlsLifetime occupational historyEver employed in funeral home orcrematoriumLeukemia2.1 (0.4--10.0)Non-Hodgkin lymphoma3.2 (0.8--13.4)Partanen et al. (1993), Finland \[[@CR50]\]Nested case control study, Cohort with workers in wood industry (*n* = 7307); Leukemia (*n* = 12), Hodgkin lymphoma (*n* = 4) and Non-Hodgkin lymphoma (*n* = 8); Matched by year of birth and vital status in 1983. Leukemia (n = 73), Hodgkin lymphoma (*n* = 21) and Non-Hodgkin lymphoma (*n* = 52)Work history from company records complemented for cases only by interviews with plant personnel and questionnaires completed by subjects or next of kin; plant- and period-specific job--exposure matrixLeukemia≥ 3 ppm-months1.40 (0.25--7.91)Hodgkin diseases≥ 3 ppm-months-Non-Hodgkin disease≥ 3 ppm-months4.24 (0.68--26.6)Blair et al. (2001), USA \[[@CR51]\]513 white men, 30 ≥ years, from the Cancer Registry of Iowa and a surveillance network of hospitals in Minnesota; 132 acute myeloid, 46 chronic myeloid leukemia cases; 1087 controls by random-digit dialing, frequency matched by 5-year age group, vital status at time of interview and state of residencePersonal interviews including lifetime occupational history; formaldehyde assessed in a blinded shion in terms of probability and intensity, each on a 4-point scale based on job title and industryAcute myeloid leukemiaLow-medium0.9 (0.5--1.6)High-Chronic myeloid leukemiaLow-medium1.3 (0.6--3.1)High2.9 (0.3--24.5)Hauptmann et al. (2009), USA \[[@CR52]\]168 professionals in the funeral industry and died from lymphohematopoietic malignancies; 265 matched controls were randomly selected from individuals in the same industry whose deaths were attributed to other causes and were stratified to be similar to the case subjects with respect to data source, sex, and dates of birth and death (5-year intervals); 1960--86.Life time work practices and exposures in the funeral industry, which were obtained by interviews with next of kin and coworkers, and to estimated levels of formaldehyde exposure.Myeloid LeukemiaEmbalming ever11.2 (1.3--95.6)Duration of embalming (year)\> 0--205.0 (0.5--51.6)\> 20--3412.9 (1.4--117.1)\> 3413.6 (1.6--119.7)*p*-trend0.020\< 500 embalmings1.0 (Ref.)Duration of embalming (year)≤200.5 (0.1--2.9)\> 20--343.2 (1.0--10.1)\> 343.9 (1.2--12.5)*p*-trend0.020OR, Odds ratioTable 9Meta-analysis of formaldehyde exposure and lymphohemtopoietic malignanciesAuthors, (Years)StudiesOverall OR or RR (95% CI)Collins et al. (2004) \[[@CR53]\]All studies for for leukemia\
Industrial workers\
Embalmers\
Pathologists and anatomist1.1 (1.0--1.2)\
0.9 (0.8--1.0)\
1.6 (1.2--2.0)\
1.4 (1.0--1.4)Bosetti et al. (2008) \[[@CR37]\]All LHMIndustrial workers0.85 (0.74--0.96)Professionals1.31 (1.16--1.48)LeukemiaIndustrial workers0.90 (0.75--1.07)Professionals1.39 (1.15--1.68)Zhang et al. (2009) \[[@CR54]\]All LHM\
All leukemia\
Myeloid leukemia\
Hodgkin lymphoma\
Non-Hodgkin lymphoma\
Multiple myeloma1.25 (1.12--1.39)\
1.54 (1.18--2.00)\
1.90 (1.31--2.76)\
1.23 (0.67--2.29)\
1.08 (0.86--1.35)\
1.31 (1.02--1.67)Bachand et al. (2010) \[[@CR38]\]All leukemia\
Professional/technical workers\
Industrial workers\
Myeloid leukemia\
Lymphoid leukemia1.05 (0.93--1.20)\
1.28 (0.98--1.66)\
0.99 (0.86--1.15)\
1.09 (0.84--1.40)\
1.11 (0.81--1.52)Schwik et al. (2010) \[[@CR55]\]All leukemia\
Professional workers\
Industry workers\
Healthy-worker effect adjusted\
Myeloid leukemia\
Healthy-worker effect adjusted1.53 (1.11--2.21)\
2.27 (1.15--4.45)\
1.38 (0.96--1.99)\
1.72 (1.18--2.51)\
2.47 (1.42--4.27)\
2.77 (1.39--5.52)LHM, Lymphohematopoietic malignancies

Biological plausibility {#Sec8}
-----------------------

There is no clear carcinogenic mechanism regarding formaldehyde exposure and NPC or LHM. However, formaldehyde exposure can lead to the formation of DNA-protein crosslinks in vitro, as well as genotoxicity in human nasal cells and disruption of bone marrow stem cells, hematopoietic stem cells, circulating progenitor cells, and primitive pluripotent stem cells \[[@CR58], [@CR59]\]. Chromosomal aneuploidy in circulating myeloid progenitor cells has also been identified among healthy workers who were exposed to formaldehyde \[[@CR60]\].

Criteria for recognizing formaldehyde as an occupational carcinogen {#Sec9}
-------------------------------------------------------------------

The IARC classified formaldehyde as a definite human carcinogen (Group 1) for NPC in 2004 and leukemia (especially myeloid leukemia) in 2012. Formaldehyde was also classified as a suspected human carcinogen (Group 2A) for sino-nasal cancer in 2012 \[[@CR3], [@CR4]\]. The American National Toxicology Program (NTP) also classified formaldehyde as a 'known human carcinogen' in 2011 \[[@CR61]\]. Furthermore, the EU CLP classified formaldehyde as a class 1B carcinogen, which indicates that the substance has presumed carcinogenic potential in humans, based on experimental animal data \[[@CR6]\].

The ILO includes 20 carcinogens on its list of occupational cancers, although it does not define the related cancers. The tripartite commission of ILO included formaldehyde on its list of potential carcinogens, although formaldehyde was not included in the final list in 2009, as employers demanded a deeper review of the data \[[@CR8], [@CR9]\]. South Korea, France, Denmark, Malaysia, and Taiwan have clearly recognized the relationship between occupational cancer and formaldehyde exposure \[[@CR9]--[@CR11]\]. France also recognized that NPC could be caused by exposure to formaldehyde or its polymers in 2009 \[[@CR10]\]. However, the list of recognized occupational diseases in Finland does not include formaldehyde-related cancers, although it was considered in the "Memorandum from the Occupational Cancer Working Group 2013" \[[@CR62]\]. Moreover, the EU only recognizes a relationship between formaldehyde exposure and NPC, as there is insufficient epidemiological evidence regarding LHM \[[@CR63]\].

Compensation cases and considerations for approval {#Sec10}
--------------------------------------------------

South Korea has not compensated any cases that were related to formaldehyde exposure itself, although some cases have been compensated after mixed exposures to other chemicals. In 2012, a 61-year-old man developed multiple myeloma after working at a poultry farm for 16 years and being exposed to agricultural chemicals (pesticides and/or organic solvents, such as formaldehyde), with an average estimated formaldehyde exposure level of 17.53 ppm \[[@CR64]\]. A 43-year-old man was diagnosed with myelodysplastic syndrome after working in a furniture manufacturing factory for 22 years. In 2013, the man's tasks involved cutting and fabricating medium-density fiberboard, as well as pasting and polishing veneer. He was exposed to benzene and formaldehyde (a TWA concentration of 0.312 ppm/8 h), which corresponded to a cumulative level of 6962--10,016 ppm·hour, and a cumulative benzene exposure of 1.88--11.25 ppm·year \[[@CR65]\].

Recognition criteria and consideration issues {#Sec11}
---------------------------------------------

Since 2013, the occupational disease criteria of the Enforcement Decree Industrial Accidents Compensation Insurance Act has included "leukemia or NPC caused by formaldehyde exposure" \[[@CR2]\]. However, there is little evidence regarding the cumulative exposure level, minimum exposure duration, extent of exposure, and combined exposure or latent period. The results from the NCI cohort and the World Trade Center Health Program suggest latent periods of approximately 15 years for NPC and 2 years for LHM, based on statistical modeling and epidemiological studies \[[@CR19], [@CR46], [@CR66]\]. In addition, the EU's "Information notices on occupational diseases: a guide to diagnosis" suggest a 10-year latent period for NPC and 6 months for the minimum exposure duration, despite the absence of definitive scientific evidence \[[@CR63]\]. The results from NCI cohort studies also suggest that peak exposures of ≥4.0 ppm were important for LHM and Hodgkin lymphoma \[[@CR20], [@CR47]\]. Finally, there is a considerable risk of combined formaldehyde exposure, as the known environmental risk factors for NPC include Epstein-Barr virus infection, consuming salted fish and reserved food spicy food, chronic ear-nose-and-throat conditions, and occupational exposures (e.g., wood dust, industrial heat or combustion products, cotton dust, and solvents, such as phenoxy acid and chlorophenol). These factors must also be considered when determining whether cases are eligible for compensation \[[@CR67], [@CR68]\]. Moreover, exposure to benzene, 1,3-butadiene, or ethylene oxide is also an important risk for LHM \[[@CR69]\].

Discussion {#Sec12}
==========

The IARC and NTP have classified formaldehyde as a definite human carcinogen, although the US EPA, ACGIH, and EU CLP disagree with this classification \[[@CR4]--[@CR7]\]. A few countries, including South Korea, have also listed formaldehyde as an occupational carcinogen \[[@CR2], [@CR9]--[@CR11]\] because of the relatively low risks of NPC or LHM in meta-analyses and cohort studies (vs. other occupational cancers). Furthermore, it is difficult to quantify FORMALDEHYDE exposure and NPC has a very low incidence (approximately 1/100,000 population) \[[@CR70]\]. However, there is sufficient epidemiological evidence to confirm associations with LHM and Hodgkin lymphoma, especially in terms of peak exposure, based on a recent update of the NCI cohort, three recent meta-analyses, and a nested case-control study of embalmers \[[@CR4], [@CR47]\].

In South Korea, the peak exposure in various industries was 2.70--14.8 ppm, and the TWA exposure level was 1.0--62.5 ppm in work-environment measurements. Thus, the risk of NPC or LHM could be increased among South Korean pathologists, anatomy students, and furniture workers with a peak exposure of ≥4 ppm \[[@CR13]--[@CR15], [@CR17]\]. In most regions, the age-standardized incidence of NPC among men and women is \< 1/100,000 person-years \[[@CR70]\]. However, dramatically elevated rates are observed in the Cantonese population of southern China (including Hong Kong) \[[@CR68]\]. These regional differences may be related to environmental risk factors, such as Epstein-Barr virus infection, and/or diet \[[@CR67]\]. Thus, we suggest that both occupational exposure and environmental risk factors should be considered in the process of approving LHM cases for workers' compensation.

The present study provided a review of the recent epidemiological evidence regarding the relationships between formaldehyde exposure and NPC or LHM, as well as a discussion regarding factors that could influence the recognition of formaldehyde-related cancers as occupational cancers. However, there is insufficient data regarding peak exposure levels and average exposure levels in various South Korean industries and jobs. Thus, additional studies are needed to help develop compensation policy and achieve scientific consensus.

Conclusion {#Sec13}
==========

We identified causal relationships and significant dose-response relationships between formaldehyde exposure and NPC, all LHM, and Hodgkin lymphoma. Furthermore, it appears that peak exposure is the most relevant factor when considering whether to officially recognize formaldehyde-related occupational cancers. Therefore, it is important to control formaldehyde exposure to protect workers and prevent them from developing NPC or LHM.

ACGIH

:   American Conference of Governmental Industrial Hygienists

EPA

:   Environmental Protection Agency

EU CLP

:   European Union Occupational Disease Classification, Labelling and Packaging of Substances and Mixtures

IARC

:   International Agency for Research on Cancer

ILO

:   International Labor Organization

LHM

:   lymphohematopoietic malignancies

NCI

:   National Cancer Institute

NPC

:   nasopharyngeal cancer

NTP

:   National Toxicology Program

TLV-TWA

:   threshold limit value-time weighted average
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